Stem tech stock12/14/2023 ![]() ![]() 6 ) A $25,000 Convertible Note to our Independent Director Darryl Green of 01/07/21, if converted to be at a 33% discount to market. 5) A $100,000 Convertible Note to Greg Guy of 12/10/20, if converted to be at a 33% discount to market. 4) A $25,000 Convertible Note to our Independent Director Darryl Green of 12/10/20, no call date, no interest, if converted to be at a 33% discount to market. 3) A Convertible Note of $25,000 to our CEO Charles Arnold executed on 12/10/20, no call date, no interest, if converted to be at a 33% discount to market. These Notes include: 1) a Convertible Note of $568,182.00 to MCUS, LLC of 09/13/21 see our 8K filed 09/10/21. This was fully disclosed in our 8K of August 20 th, 2021 and exhibits thereto.Īs for currently existing debts, there are several Convertible Notes to two SIPC licensed Funds and several related people, none of which has been converted to date. The Company was queried as to the increased trading activity of July 8 th, for which we have no explanation other than the possibility that this advertisement may have affected the market price.Īt the time of the merger between this issuer and the new management in August, 2021, by agreement of all then existing debt holders and old management, all pre-existing debts were converted out to 6,000,000 shares, which equates to $0.09 per share. Neither the Company or any its Officers or third-party consultants had any knowledge of, or were involved in any way, with this promotion. In spite of the fact that the Company wholly disavows any knowledge of or connection to this release, the facts disclosed therein regarding our CEO’s business accomplishments are in fact accurate. The statements regarding the potential meteoric rise in our share price is specious and baseless, and by any objective standard should be ignored. Neither the Board nor our sole IR specialist, Winthorp Capital, have any knowledge of or involvement with said unknown third-party promotion and would have remained ignorant of it but for the notice received from OTC Markets.Īccording to the copy of the promotion provided for review by OTCMarkets, the web site publishing the stock promotion was The Company has reviewed said release and determined that the information posted was obtained from public information, the Company’s website and possibly certain filings by the Company with the SEC. ![]() This promotion apparently based their material solely upon the past history of one of our Directors from publicly available material. ![]() ![]() This press release is made by the Board to publicly comment on this Notice received by OTC Markets.Īt close of business this past Friday, July 8 th, OTC Markets notified our Company of a foreign stock promotion which we were unaware of, and provided Stemtech Corporation with a copy of an article from a UK web site called “World Finance”, which emphatically predicted share price appreciation in the Stem Cell arena in general, and our Company in particular. MIRAMAR, FL, J(GLOBE NEWSWIRE) - Stemtech Corporation (“Stemtech”) (OTCQB:STEK), was notified by OTC Markets at close of business Friday July 8 th regarding a certain stock promotion which relates to our company’s stock. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |